QuidelOrtho QDEL Stock
QuidelOrtho Price Chart
QuidelOrtho QDEL Financial and Trading Overview
QuidelOrtho stock price | 28.36 USD |
Previous Close | 65.57 USD |
Open | 65.37 USD |
Bid | 69.84 USD x 800 |
Ask | 69.92 USD x 3000 |
Day's Range | 65.37 - 70.16 USD |
52 Week Range | 57.54 - 98.67 USD |
Volume | 385.27K USD |
Avg. Volume | 522.89K USD |
Market Cap | 4.68B USD |
Beta (5Y Monthly) | 0.373 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -30.54 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 96.57 USD |
QDEL Valuation Measures
Enterprise Value | 6.85B USD |
Trailing P/E | N/A |
Forward P/E | 13.471155 |
PEG Ratio (5 yr expected) | 1.81 |
Price/Sales (ttm) | 1.4993914 |
Price/Book (mrq) | 0.94214016 |
Enterprise Value/Revenue | 2.195 |
Enterprise Value/EBITDA | 8.992 |
Trading Information
QuidelOrtho Stock Price History
Beta (5Y Monthly) | 0.373 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 98.67 USD |
52 Week Low | 57.54 USD |
50-Day Moving Average | 66.23 USD |
200-Day Moving Average | 79.58 USD |
QDEL Share Statistics
Avg. Volume (3 month) | 522.89K USD |
Avg. Daily Volume (10-Days) | 490.34K USD |
Shares Outstanding | 66.82M |
Float | 50.63M |
Short Ratio | 6.62 |
% Held by Insiders | 7.10% |
% Held by Institutions | 97.24% |
Shares Short | 3.79M |
Short % of Float | 7.08% |
Short % of Shares Outstanding | 5.67% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | October 1, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 0.42% |
Operating Margin (ttm) | 7.09% |
Gross Margin | 50.03% |
EBITDA Margin | 24.41% |
Management Effectiveness
Return on Assets (ttm) | 2.21% |
Return on Equity (ttm) | 0.27% |
Income Statement
Revenue (ttm) | 3.12B USD |
Revenue Per Share (ttm) | 46.8 USD |
Quarterly Revenue Growth (yoy) | -5.099% |
Gross Profit (ttm) | 1.94B USD |
EBITDA | 762.1M USD |
Net Income Avi to Common (ttm) | 13.2M USD |
Diluted EPS (ttm) | -0.27 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 198.1M USD |
Total Cash Per Share (mrq) | 2.97 USD |
Total Debt (mrq) | 2.67B USD |
Total Debt/Equity (mrq) | 53.75 USD |
Current Ratio (mrq) | 1.595 |
Book Value Per Share (mrq) | 74.352 |
Cash Flow Statement
Operating Cash Flow (ttm) | 369.2M USD |
Levered Free Cash Flow (ttm) | 387.56M USD |
Profile of QuidelOrtho
Country | United States |
State | CA |
City | San Diego |
Address | 9975 Summers Ridge Road |
ZIP | 92121 |
Phone | 858 552 1100 |
Website | https://www.quidelortho.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 7000 |
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
Q&A For QuidelOrtho Stock
What is a current QDEL stock price?
QuidelOrtho QDEL stock price today per share is 28.36 USD.
How to purchase QuidelOrtho stock?
You can buy QDEL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for QuidelOrtho?
The stock symbol or ticker of QuidelOrtho is QDEL.
Which industry does the QuidelOrtho company belong to?
The QuidelOrtho industry is Medical Devices.
How many shares does QuidelOrtho have in circulation?
The max supply of QuidelOrtho shares is 67.45M.
What is QuidelOrtho Price to Earnings Ratio (PE Ratio)?
QuidelOrtho PE Ratio is now.
What was QuidelOrtho earnings per share over the trailing 12 months (TTM)?
QuidelOrtho EPS is -30.54 USD over the trailing 12 months.
Which sector does the QuidelOrtho company belong to?
The QuidelOrtho sector is Healthcare.
QuidelOrtho QDEL included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 19098.57 USD — |
+0.1
|
— — | 18095.83 USD — | 19941.93 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2497.76 USD — |
-0.11
|
— — | 2369.22 USD — | 2594.76 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 7634.31 USD — |
+0.11
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
- {{ link.label }} {{link}}